US guidance on avoidance of patient bed entrapment
This article was originally published in Clinica
Executive Summary
The US FDA has issued a final guidance on designing hospital beds that will reduce the occurrence of potentially fatal patient entrapment. Over the last two decades, 413 patients have died and 120 have been injured after becoming trapped in their beds. Entrapment can occur when a portion of a patient's body becomes caught between parts of the bed, typically involving the bed's side-rail.
You may also be interested in...
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.
Sandoz And Samsung Celebrate Stelara Rival’s EU Approval
Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.